{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:06:26Z","timestamp":1771063586807,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"S19","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12859-018-2529-z","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T03:43:12Z","timestamp":1546227792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Computational prediction of plasma protein binding of cyclic peptides from small molecule experimental data using sparse modeling techniques"],"prefix":"10.1186","volume":"19","author":[{"given":"Takashi","family":"Tajimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Ohue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"6","key":"2529_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/bip.22900","volume":"106","author":"D Leenheer","year":"2016","unstructured":"Leenheer D, Ten Dijke P, Hipolito CJ. A current perspective on applications of macrocyclic-peptide-based high-affinity ligands. Biopolymers. 2016;106(6):889\u2013900.","journal-title":"Biopolymers"},{"issue":"3","key":"2529_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1517\/17460441.2012.661554","volume":"7","author":"DJ Craik","year":"2012","unstructured":"Craik DJ, Swedberg JE, Mylne JS, Cemazar M. Cyclotides as a basis for drug design. Expert Opin Drug Discov. 2012;7(3):179\u201394.","journal-title":"Expert Opin Drug Discov"},{"issue":"7","key":"2529_CR3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1021\/acs.accounts.7b00157","volume":"50","author":"SJ Veer de","year":"2017","unstructured":"de Veer SJ, Weidmann J, Craik DJ. Cyclotides as tools in chemical biology. Acc Chem Res. 2017;50(7):1557\u201365.","journal-title":"Acc Chem Res"},{"key":"2529_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejmech.2014.07.083","volume":"94","author":"A Bhat","year":"2015","unstructured":"Bhat A, Roberts LR, Dwyer JJ. Lead discovery and optimization strategies for peptide macrocycles. Eur J Med Chem. 2015;94:471\u20139.","journal-title":"Eur J Med Chem"},{"issue":"35","key":"2529_CR5","doi-asserted-by":"publisher","first-page":"10294","DOI":"10.1002\/anie.201611914","volume":"56","author":"E Valeur","year":"2017","unstructured":"Valeur E, Gu\u00e9ret SM, Adihou H, Gopalakrishnan R, Lemurell M, Waldmann H, Grossmann TN, Plowright AT. New modalities for challenging targets in drug discovery. Angew Chem Int Ed Engl. 2017;56(35):10294\u2013323.","journal-title":"Angew Chem Int Ed Engl."},{"issue":"9","key":"2529_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nchembio.1605","volume":"10","author":"HCD discovery","year":"2014","unstructured":"discovery HCD. Tools and rules for macrocycles. Nat Chem Biol. 2014;10(9):696\u20138.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"2529_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0929867003375074","volume":"7","author":"W Wang","year":"2000","unstructured":"Wang W, Borchardt RT, Wang B. Orally active peptidomimetic RGD analogs that are glycoprotein IIb\/IIIa antagonists. Curr Med Chem. 2000;7(4):437\u201353.","journal-title":"Curr Med Chem"},{"issue":"14","key":"2529_CR8","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/anie.200705797","volume":"47","author":"E Biron","year":"2008","unstructured":"Biron E, Chatterjee J, Ovadia O, Langenegger D, Brueggen J, Hoyer D, Schmid HA, Jelinek R, Gilon C, Hoffman A, Kessler H. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew Chem Int Ed Engl. 2008;47(14):2595\u20139.","journal-title":"Angew Chem Int Ed Engl."},{"issue":"11","key":"2529_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nchembio.664","volume":"7","author":"TR White","year":"2011","unstructured":"White TR, Renzelman CM, Rand AC, Rezai T, McEwen CM, Gelev VM, et al. On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nat Chem Biol. 2011;7(11):810\u20137.","journal-title":"Nat Chem Biol"},{"issue":"49","key":"2529_CR10","doi-asserted-by":"publisher","first-page":"17504","DOI":"10.1073\/pnas.1417611111","volume":"111","author":"CK Wang","year":"2014","unstructured":"Wang CK, Northfield SE, Colless B, Chaousis S, Hamernig I, Lohman RJ, et al. Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients. Proc Natl Acad Sci U S A. 2014;111(49):17504\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"45","key":"2529_CR11","doi-asserted-by":"publisher","first-page":"12059","DOI":"10.1002\/anie.201405364","volume":"53","author":"DS Nielsen","year":"2014","unstructured":"Nielsen DS, Hoang HN, Lohman RJ, Hill TA, Lucke AJ, Craik DJ, et al. Improving on nature: making a cyclic heptapeptide orally bioavailable. Angew Chem Int Ed Engl. 2014;53(45):12059\u201363.","journal-title":"Angew Chem Int Ed Engl."},{"issue":"23","key":"2529_CR12","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1002\/anie.201200984","volume":"51","author":"CT Wong","year":"2012","unstructured":"Wong CT, Rowlands DK, Wong CH, Lo TW, Nguyen GK, Li HY, Tam JP. Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. Angew Chem Int Ed Engl. 2012;51(23):5620\u20134.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"37","key":"2529_CR13","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1002\/anie.201000620","volume":"49","author":"RJ Clark","year":"2010","unstructured":"Clark RJ, Jensen J, Nevin ST, Callaghan BP, Adams DJ, Craik DJ. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl. 2010;49(37):6545\u20138.","journal-title":"Angew Chem Int Ed Engl."},{"key":"2529_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cbpa.2017.02.006","volume":"38","author":"A Zorzi","year":"2017","unstructured":"Zorzi A, Deyle K, Heinis C. Cyclic peptide therapeutics: past, present and future. Curr Opin Chem Biol. 2017;38:24\u20139.","journal-title":"Curr Opin Chem Biol"},{"key":"2529_CR15","doi-asserted-by":"publisher","first-page":"S604","DOI":"10.1093\/cid\/civ814","volume":"61","author":"D Aguilar-Zapata","year":"2015","unstructured":"Aguilar-Zapata D, Petraitiene R, Petraitis V. Echinocandins: the expanding antifungal armamentarium. Clin Infect Dis. 2015;61:S604\u201311.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2529_CR16","first-page":"169","volume":"31","author":"IM Modlin","year":"2010","unstructured":"Modlin IM, Pavel M, Kidd M, Gustafsson BI. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Aliment Pharmacol Ther. 2010;31(2):169\u201388.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2529_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1530\/eje.0.1460707","volume":"146","author":"C Bruns","year":"2002","unstructured":"Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol. 2002;146(5):707\u201316.","journal-title":"Eur J Endocrinol"},{"key":"2529_CR18","first-page":"37","volume":"2","author":"S Jain","year":"2011","unstructured":"Jain S, Zain J. Romidepsin in the treatment of cutaneous T-cell lymphoma. J Blood Med. 2011;2:37\u201347.","journal-title":"J Blood Med"},{"issue":"1","key":"2529_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640612474446","volume":"1","author":"M Corsetti","year":"2013","unstructured":"Corsetti M, Tack J. Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation. United European Gastroenterol J. 2013;1(1):7\u201320.","journal-title":"United European Gastroenterol J"},{"issue":"21","key":"2529_CR20","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1021\/jm0706970","volume":"50","author":"V Goncalves","year":"2007","unstructured":"Goncalves V, Gautier B, Coric P, Bouaziz S, Lenoir C, Garbay C, et al. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor. J Med Chem. 2007;50(21):5135\u201346.","journal-title":"J Med Chem"},{"issue":"9","key":"2529_CR21","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1128\/AAC.48.9.3349-3357.2004","volume":"48","author":"V Frecer","year":"2004","unstructured":"Frecer V, Ho B, Ding JL. De novo design of potent antimicrobial peptides. Antimicrob Agents Chemother. 2004;48(9):3349\u201357.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2529_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/cmdc.201600082","volume":"11","author":"M Fouche","year":"2016","unstructured":"Fouche M, Sch\u00e4fer M, Berghausen J, Desrayaud S, Blatter M, Pi\u00e9chon P, et al. Design and development of a cyclic decapeptide scaffold with suitable properties for bioavailability and oral exposure. ChemMedChem. 2016;11(10):1048\u201359.","journal-title":"ChemMedChem"},{"issue":"8","key":"2529_CR23","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1021\/acs.accounts.7b00184","volume":"50","author":"K Deyle","year":"2017","unstructured":"Deyle K, Kong XD, Heinis C. Phage selection of cyclic peptides for application in research and drug development. Acc Chem Res. 2017;50(8):1866\u201374.","journal-title":"Acc Chem Res"},{"issue":"12","key":"2529_CR24","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1039\/C6CC06951G","volume":"53","author":"T Passioura","year":"2017","unstructured":"Passioura T, Suga H. A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets. Chem Commun. 2017;53(12):1931\u201340.","journal-title":"Chem Commun"},{"issue":"6","key":"2529_CR25","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.bmc.2018.01.013","volume":"26","author":"T Passioura","year":"2018","unstructured":"Passioura T, Bhushan B, Tumber A, Kawamura A, Suga H. Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A. Bioorg Med Chem. 2018;26(6):1225\u201331.","journal-title":"Bioorg Med Chem"},{"key":"2529_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-4939-7454-2_3","volume":"1700","author":"T Kusakizako","year":"2018","unstructured":"Kusakizako T, Tanaka Y, Hipolito CJ, Suga H, Nureki O. Crystallographic analysis of MATE-type multidrug exporter with its inhibitors. Methods Mol Biol. 2018;1700:37\u201357.","journal-title":"Methods Mol Biol"},{"issue":"24","key":"2529_CR27","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1039\/C7OB00012J","volume":"15","author":"X Song","year":"2017","unstructured":"Song X, Lu LY, Passioura T, Suga H. Macrocyclic peptide inhibitors for the protein\u2013protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. Org Biomol Chem. 2017;15(24):5155\u201360.","journal-title":"Org Biomol Chem"},{"issue":"11","key":"2529_CR28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.chembiol.2016.09.015","volume":"23","author":"Y Matsunaga","year":"2016","unstructured":"Matsunaga Y, Bashiruddin NK, Kitago Y, Takagi J, Suga H. Allosteric inhibition of a semaphorin 4D receptor plexin B1 by a high-affinity macrocyclic peptide. Cell Chem Biol. 2016;23(11):1341\u201350.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"2529_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000220395","volume":"10","author":"E Kr\u00fcger-Thiemer","year":"1965","unstructured":"Kr\u00fcger-Thiemer E, B\u00fcnger P. The role of the therapeutic regimen in dosage design. I Chemotherapy. 1965;10(2):61\u201373.","journal-title":"I Chemotherapy"},{"key":"2529_CR30","unstructured":"Benet LZ, Kroetz DL, Sheiner LB. Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination. Goodman and Gilman\u2019s the pharmacological basis of therapeutics. 1996:3\u201327."},{"issue":"25","key":"2529_CR31","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1021\/jm970417o","volume":"40","author":"M Rowley","year":"1997","unstructured":"Rowley M, Kulagowski JJ, Watt AP, Rathbone D, Stevenson GI, Carling RW, et al. Effect of plasma protein binding on in vivo activity and brain penetration of glycine\/NMDA receptor antagonists. J Med Chem. 1997;40(25):4053\u201368.","journal-title":"J Med Chem"},{"key":"2529_CR32","first-page":"327","volume":"31","author":"RE Olson","year":"1996","unstructured":"Olson RE, David DC. Plasma protein binding of drugs. Annu Rep Med Chem. 1996;31:327\u201336.","journal-title":"Annu Rep Med Chem"},{"key":"2529_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrd3287","volume":"9","author":"DA Smith","year":"2010","unstructured":"Smith DA, Di L, Kerns EH. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 2010;9:929\u201339.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2529_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093323","volume":"9","author":"KW Lexa","year":"2014","unstructured":"Lexa KW, Dolghih E, Jacobson MP. A structure-based model for predicting serum albumin binding. PLoS One. 2014;9(4):e93323.","journal-title":"PLoS One"},{"issue":"24","key":"2529_CR35","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.1021\/jm051245v","volume":"49","author":"JR Votano","year":"2006","unstructured":"Votano JR, Parham M, Hall LM, Hall LH, Kier LB, Oloff S, Tropsha A. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation. J Med Chem. 2006;49(24):7169\u201381.","journal-title":"J Med Chem"},{"issue":"11","key":"2529_CR36","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1021\/acs.jcim.6b00291","volume":"56","author":"BL Ingle","year":"2016","unstructured":"Ingle BL, Veber BC, Nichols JW, Tornero-Velez R. Informing the human plasma protein binding of environmental chemicals by machine learning in the pharmaceutical space: applicability domain and limits of predictability. J Chem Inf Model. 2016;56(11):2243\u201352.","journal-title":"J Chem Inf Model"},{"issue":"7","key":"2529_CR37","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1007\/s11095-013-1023-6","volume":"30","author":"XW Zhu","year":"2013","unstructured":"Zhu XW, Sedykh A, Zhu H, Liu SS, Tropsha A. The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding. Pharm Res. 2013;30(7):1790\u20138.","journal-title":"Pharm Res"},{"issue":"6","key":"2529_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/cmdc.201700582","volume":"13","author":"L Sun","year":"2018","unstructured":"Sun L, Yang H, Li J, Wang T, Li W, Liu G, Tang Y. In silico prediction of compounds binding to human plasma proteins by QSAR models. ChemMedChem. 2018;13(6):572\u201381.","journal-title":"ChemMedChem"},{"issue":"D1","key":"2529_CR39","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2013","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2013;42(D1):D1091\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2529_CR40","first-page":"1373","volume":"27","author":"H Kurz","year":"1977","unstructured":"Kurz H, Trunk H, Weitz B. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arzneimittelforschung. 1977;27(7):1373\u201380.","journal-title":"Arzneimittelforschung"},{"key":"2529_CR41","volume-title":"Schr\u00f6dinger","author":"Schr\u00f6dinger Release 2017\u20134","year":"2017","unstructured":"Schr\u00f6dinger Release 2017\u20134. QikProp. In: Schr\u00f6dinger. New York: LLC; 2017."},{"key":"2529_CR42","volume-title":"Schr\u00f6dinger","author":"Schr\u00f6dinger Release 2017\u20134","year":"2017","unstructured":"Schr\u00f6dinger Release 2017\u20134. LigPrep. In: Schr\u00f6dinger. New York: LLC; 2017."},{"key":"2529_CR43","first-page":"1985","volume-title":"Proceedings of the 31st AAAI conference on Articial intelligence (AAAI\u201917)","author":"S Hara","year":"2017","unstructured":"Hara S, Maehara T. Enumerate lasso solutions for feature selection. In: Proceedings of the 31st AAAI conference on Articial intelligence (AAAI\u201917); 2017. p. 1985\u201391."},{"issue":"3","key":"2529_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1021\/acsinfecdis.7b00015","volume":"3","author":"EK Schneider","year":"2017","unstructured":"Schneider EK, Huang JX, Carbone V, Han M, Zhu Y, Nang S, et al. Plasma protein binding structure-activity relationships related to the N-terminus of Daptomycin. ACS Infect Dis. 2017;3(3):249\u201358.","journal-title":"ACS Infect Dis"},{"issue":"1","key":"2529_CR45","first-page":"139","volume":"39","author":"B Ren","year":"1999","unstructured":"Ren B. A new topological index for QSPR of alkanes. J Chem Conput Sci. 1999;39(1):139\u201343.","journal-title":"J Chem Conput Sci"},{"key":"2529_CR46","doi-asserted-by":"crossref","unstructured":"Todeschini R, Consonni V. Molecular descriptors for Chemoinformatics: Wiley-VCH; 2009.","DOI":"10.1002\/9783527628766"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2529-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-018-2529-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2529-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T19:03:35Z","timestamp":1577732615000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-018-2529-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"journal-issue":{"issue":"S19","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1186\/s12859-018-2529-z","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"31 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"527"}}